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Abstract. Altered antioxidant status has been reported in schizophrenia. The glutathione (GSH) redox system is important for
reducing oxidative stress. GSH, a radical scavenger, is converted to oxidized glutathione (GSSG) through glutathione peroxidase
(GPx), and converted back to GSH by glutathione reductase (GR). Measurements of GSH, GSSG and its related enzymatic
reactions are thus important for evaluating the redox and antioxidant status. In the present study, levels of GSH, GSSG, GPx
and GR were assessed in the caudate region of postmortem brains from schizophrenic patients and control subjects (with and
without other psychiatric disorders). Signiﬁcantly lower levels of GSH, GPx, and GR were found in schizophrenic group than in
control groups without any psychiatric disorders. Concomitantly, a decreased GSH:GSSG ratio was also found in schizophrenic
group. Moreover, both GSSG and GR levels were signiﬁcantly and inversely correlated to age of schizophrenic patients, but not
control subjects. No signiﬁcant differences were found in any GSH redox measures between control subjects and individuals
with other types of psychiatric disorders. There were, however, positive correlations between GSH and GPx, GSH and GR, as
well as GPx and GR levels in control subjects without psychiatric disorders. These positive correlations suggest a dynamic state
is kept in check during the redox coupling under normal conditions. By contrast, lack of such correlations in schizophrenia point
to a disturbance of redox coupling mechanisms in the antioxidant defense system, possibly resulting from a decreased level of
GSH as well as age-related decreases of GSSG and GR activities.
Keywords: Glutathione, glutathione disulﬁde, glutathione peroxidase, glutathione reductase, cigarette smoking, age, postmortem
caudate, schizophrenia
1. Introduction
Biological systems have evolved complex protec-
tive strategies against free radical toxicity [1]. Under
physiological conditions the potential for free radical-
mediated damage is kept in check by the antioxidant
defense system, comprising a series of enzymatic and
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non-enzymatic components (Fig. 1). The key antiox-
idant enzymes include superoxide dismutase (SOD),
catalase (CAT), and glutathione peroxidase (GSH-Px).
Superoxide dismutase catalyzes the conversion of su-
peroxideradicals (O
−
2 •) to hydrogenperoxide(H2O2),
which in turn can form the highly reactive hydroxyl
radicals. Catalase and glutathione peroxidase convert
hydrogen peroxide to water. Glutathione (GSH) is uti-
lized by GSH-Px to yield the oxidized form of glu-
tathione (GSSG), which is converted back to GSH by
glutathione reductase (GR). In addition, nitric oxide
(NO) which is the product of a ﬁve-electron oxidation
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Fig. 1. Production of reactive oxygen species and defense mech-
anism against damage by reactive oxygen. Abbreviations: O
−
2 •,
superoxide radicals; SOD, superoxide dismutase; H2O2, hydrogen
peroxide; CAT, catalase; GPx, glutathione peroxidase; GSH, glu-
tathione; GSSG, glutathione disulﬁde; GR, glutathione reductase,
OH•, hydroxyl radicals.
oftheaminoacidL-arginine,canalsoproducehydroxyl
radicals as well as nitrogen dioxide radical.
There is evidence that free radicals are involved
in membrane pathology, and may play a role in
schizophrenia [2–4]. Membrane dysfunction can be
secondaryto free radical-mediatedpathology,and may
contribute to speciﬁc aspects of schizophrenic symp-
tomatologyand complicationsof its treatment. Specif-
ically, free radical-mediated abnormalities may con-
tribute to the development of a number of clinically
signiﬁcant consequences, including prominent nega-
tive symptoms, tardive dyskinesia, neurological “soft”
signs, poor premorbid function, and CT scan abnor-
malities. Our previous results showing altered mem-
brane dynamics and antioxidant enzyme activities in
schizophrenia, and ﬁndings from other investigators
are consistent with the notion of free radical-mediated
neurotoxicity in schizophrenia [4]. Free radicals are
reactive chemical species generated during normal
metabolic processes, and in excess, can damage lipids,
proteins, and DNA. Regions of high oxygen consump-
tion, lipid content, and transition metals, are at partic-
ular risk. Hence, neuronal membranes are uniquely
vulnerable to radical-mediated damage.
Studies of the antioxidant defense system are of-
ten complicated by cumbersome analytical methods,
which require separate and multi-step extraction and
chemical reaction procedures. Thus, measurements of
multiple parameters are limited in relatively small bi-
ological samples. Recently, we [5] have developed a
convenient and sensitive tool to measure low molecu-
lar weight, redox-active compounds in biological sam-
ples using a high-pressure liquid chromatography sys-
tem (HPLC) coupled with a 16-channel Coulometric
Multi Electrode Array System (CMEAS). The purpose
ofthepresentinvestigationwastoassesstheglutathione
(GSH) redox system (Fig. 1) by evaluating not only
GSH and GSSG levels but also the enzyme activities
of GSH-Px and GSH-R simultaneously in the caudate
regionof postmortembrainsamples frompatients with
schizophreniaaswellascontrolswithandwithoutother
psychiatric disorders.
2. Methods
2.1. Postmortem brain tissues
The Schizophrenia Research Center Brain Bank at
the VA Medical Center in Denver, Colorado, provided
postmortembraintissue. Humanbrainwas collectedat
autopsy from local services following family consent.
Psychiatric illness status was determined indepen-
dently by two board-certiﬁed psychiatrists from medi-
cal records and structured family interviews. Diagnos-
tic and Statistical Manual IV criteria for schizophre-
nia[6](AmericanPsychiatricAssociation,1994),were
met for the schizophrenic subjects used in the study.
Controlsubjects werealso evaluatedanddeterminedto
have had no evidence of psychiatric illness.
At autopsy, the brain was weighed and examined
for gross pathology. It was then divided sagittally and
one hemisphere, selected randomly, was preserved in
formalin for neuropathological analysis at the macro-
scopic and microscopiclevel. Microscopicevaluations
included standard Bielchowsky silver stain on multi-
plecerebralareasto ruleoutabnormalneuropathology,
such plaques and tangles, associated with Alzheimer’s
and other conditions. Patients with positive neuritic
ﬁndingsorambiguousneuropathologyreportswereex-
cludedfromthecurrentstudy. Thehemispherethatwas
not subjected to neuropathological analysis was sliced
coronallyinto1cmslices, fromwhichmultipleregions
weredissectedin1-gramblocks,frozenindryicesnow,
and packaged for storage at −80◦C. Hemispheres are
collected randomly.
An extensive review of hospital, autopsy, and neu-
ropathology reports were conducted to determine ago-
nal andpostmortemconditionsfor each subject. Based
upon this information, an agonal state score was as-
signed following the four-point rating scale described
by Hardy et al. [7]. These four categories included
1) violent and fast death, almost always of unnatural
causessuchas shootings(accidental,homicidal,orsui-J.K. Yao et al. / Altered glutathione redox state in schizophrenia 85
cide) or blunt force trauma; 2) fast death of natural
causes, such as the sudden, unexpected deaths of in-
dividuals who had appeared reasonably healthy. The
most common cause of death in this group was my-
ocardial infarction; 3) intermediate death, usually un-
expected,eventhoughthepatientwas ill priorto death;
and 4) slow death, occurring after a long illness. The
majority of these patients died of cancer or chronic
pulmonary disease.
Additionalpostmortemparameters,suchas age,sex,
ethnicity, medication history, psychiatric illness status,
cigarette smoking history and alcohol use, were evalu-
ated through hospital, autopsy, and neuropathologyre-
ports. Family members and physicianswere also inter-
viewed to detail the smoking and alcohol history of the
subject, including packs of cigarettes smoked per day,
and the quantity and type of alcohol consumed. All of
the subjects who had used alcohol prior to death had
consumedno morethantwo drinks perdayon average.
Smokers had used cigarettes until the time of death.
Allpatientswithschizophreniaandotherpsychiatric
disorderswereonantipsychoticmedicationsatthetime
ofdeath. Atthetimeofautopsy,thebrainwasremoved
andhemisectionedinthe sagittalplane. Onehalfofthe
cerebrum, cerebellum, and brainstem was immersed
in 10% formalin and ﬁxed for 1–2 weeks. The other
hemisphere was sliced coronally and transported on
aluminumplates, previouslychilled on ice, to the labo-
ratory for dissection. To avoid hemispheric bias, alter-
nate (left/right) hemispheres were collected. Immedi-
ately after sample collection, tissue was dissected from
approximately50areas, inonegrampieces, andfrozen
on dry ice snow. The remainder of the hemisphere
was also frozen on slabs of dry ice, and stored with
the dissected parts at −80◦C. In the present study, the
caudatenucleusfromschizophrenicandcontrolgroups
was used for GSH analyses.
2.2. Laboratory assays
2.2.1. Tissue preparation
Approximately 0.2 g of brain sample was ﬁrst
weighed and lyophilized before the dry weight was
taken. Samples were then homogenized by a Polytron
tissue homogenizer in one ml of 10 mM Sodium Ac-
etate, pH 6.5. Following centrifugation for 10 min-
utesat 3,000rpm,thecell-freehomogenatewas further
passed through a disposable membrane (0.22 µm pore
size) micropartition system (Millipore Ultrafree-MC)
under centrifugation to remove any compounds above
10,000 nominal molecular weight limit. The result-
ingprotein-freesupernatantwassubjectedtoHPLCfor
GSH and GSSG assays.
2.2.2. Measurements of GSH and GSSG by
HPLC-CMEAS
The deproteinized sample was analyzed by an ESA
CoulArrayModel5600HPLCsystemconsistingoftwo
Model 582 pumps, one dynamic gradient mixer, two
PEEKTM pulse dampers, a Model 542 refrigerated au-
tosampler injector, a CoulArray organizermodule, and
a serial arrayof 16 coulometricelectrodes. The system
iscontrolledandchromatogramsareanalyzedbyaDell
personal computer Model Dimension XPS R450 using
the ESA CoulArrayforWindows-32softwareprogram
(version 1.04).
Each sample containing 50 µL protein-free extract
was run on a single column (ESA Meta-250, 5 µm
ODS, 250 × 4.6 mm ID) with a 150-minute gradient
elution that ranged from 0% [Mobile Phase A consist-
ingof 1.1%(w/v) of1-pentane-sulfonicacid (pH, 3.0)]
to 20% Mobile Phase B (MPB, consisting of 0.1 M
lithium acetate in a solvent mixture of methanol, ace-
tonitrile and isopropanol, 80/10/10 (v/v/v) with a ﬁxed
ﬂow rate of 0.5 ml/min. The temperature of both cells
andcolumnwasmaintainedat25◦C.Similartothepre-
viously published method [9,10], the current gradient
elution also included a 2 minutes of a high-potential
cell-cleaning step to restore the column to 100% MPA
at the end of each run. The CMEAS is set to have in-
crements from 0 to 960 mV in 60 mV steps. The prop-
ertiesofvariousantioxidantcompoundsormonoamine
metabolites are often closely related to the same struc-
tural characteristics. The use of several coulometric
sensors in series that are maintained at different po-
tentials provides resolution and detection of co-eluting
compounds with different electrochemical features.
The ESA CoulArray for Windows 32 package was
used for quantitative analysis of peak identity and the
peaks relative to absolute or reference standards. This
software is able to automatically subtract backgrounds
resulting from the gradient drift. The coulometric ar-
ray is used to generate databases of all redox-active
molecules with redox potentials from 0 to 960 mV.
Peakidentityisveriﬁedbytheretentiontime,dominant
channel, and the ratio of reactivity on the dominant
channel to reactivity on the subdominant channels [9,
10]. Theconcentrationofeach peakwas calculatedac-
cordingtothedominantchannelwhichhas>70%ratio
conformity to contribute to the quantitation [11]. In a
typical assay, the standard curve for GSH and GSSG
were established between 0.2 to 200 ng that provides
three orders of magnitude. Within the range of the
standard curve, the coefﬁcients of variation (CV) for
within-run assays were in the range of 0.9–6.0% and
for between-run assays were in the range of 1.0–9.1%.86 J.K. Yao et al. / Altered glutathione redox state in schizophrenia
2.2.3. Glutathione peroxidase (GPx) assay
Approximately200 mg of brain tissue was homoge-
nized in 1.5 ml of 50 mM Tris-HCl Buffer containing
1 mM EDTA, pH 7.4. Following centrifugation of the
homogenate for 10 minutes at 8500 rpm, aliquots of
supernatant between 0.1 to 1.0 mg proteins were used
for enzyme assays.
TheCellularGlutathionePeroxidaseAssay Kit(Cat.
No. 354104) from Calbiochem was used to measure
GPx activity indirectly. In principal, GSSG that is pro-
duced upon reduction of organicperoxide by cytoplas-
mic GPx is recycled to its reduced state by glutathione
reductase (GR). The oxidation of NADPH to NADP+
is accompaniedbya decreasein absorbanceat 340nm,
which provides a spectrophotometric means of moni-
toring GPx activity.
2.2.4. Glutathione reductase (GR) assay
The Glutathione Reductase Assay Kit from Cal-
bIochem (Cat. No. 359962) was used to measure GR
activity. Brieﬂy, the GSSG is reduced by a multi-step
reaction in which GR is initially reduced by NADPH
producingasemiquinoneofFAD,asulfurradicalanda
thiol. ThereducedGR reacts witha moleculeofGSSG
resulting in a disulﬁde interchange, which produces a
moleculeofGSHandtheGSSG-Rred-SGcomplex. An
electron rearrangement in GSSG-Rred-SG results in a
second disulﬁde interchange, splitting off the second
molecule of GSH and restoring the GR to the oxidized
form. The GR activity was thus measured by the rate
of NADPH oxidation, which is accompanied by a de-
crease in absorbanceat 340 nm. Since GR is present at
rate-limiting concentration, the rate of decrease in the
A340 is directly proportional to the GR activity in the
sample.
2.3. Statistical analyses
Multiple regression analyses were conducted to de-
termine whether the brain collection and storage vari-
ables(age,postmorteminterval,brainweight,andstor-
age time) were signiﬁcantly associated with the bio-
chemical measures of interest. Separate regression
analyses were conducted for each of the biochemical
measures. The brain collection and storage measures
wereenteredintoeachoftheregressionanalysesaspre-
dictorvariables. Thedistributionsforallvariableswere
examined using normality plots and the Kolmogorov-
Smimovtest,whichquantiﬁesthediscrepancybetween
data distribution and an ideal Gaussian distribution.
The Dallal and Wilkinson approximation to Lilliefors’
method was used to compute the P values. The data
pass the normality test if p>0.10. For normally dis-
tributed data, means and variances were compared by
the use of t-tests and F-tests.
One-way analyses of variance (ANOVA) were con-
ducted to evaluate group differences for brain collec-
tion and storage parameters between schizophrenics,
controls with and without other psychiatric disorders.
Analyses of covariance (ANCOVA) were conductedto
controlstatistically for the potential effects of the brain
collection and storage variables on the group differ-
ences for the biochemical measures of interest. Group
meansfortheGSHredoxcouplingmeasureswerecom-
pared using ANOVAs, with pairwise comparisons (un-
paired t-tests) following signiﬁcant ﬁndings.
3. Results
3.1. Brain collection and storage parameters
One-way analyses of variance (ANOVA) were con-
ducted to evaluate group differences for the brain col-
lection and storage parameters (Table 1). There are
no signiﬁcant differences of age, postmortem inter-
val (PMI), and storage time among three test groups
with exception that brain weights was found signiﬁ-
cantly higher in schizophrenic than in control samples
without psychiatric disorders. The normality plots and
the Kolmogorov-Smimovtest indicated that normality
transformations of the data were not necessary. On the
other hand, as expected, the frequencyof smoking was
higher in patients with either schizophrenia or bipo-
lar and/or depression than in control subjects without
psychiatric disorders. In addition, the ratio of male to
female subjects was also higher in the patient samples
than in control samples without psychiatric disorders.
3.2. Evaluations of glutathione redox state
To evaluate GSH redoxstate, GSH and GSSG levels
were measured by HPLC coupled with a 16-channel
Coulometric Electrode Array System. GSH-Px and
GSSG-R activities were assayed by a spectrophoto-
metric procedure in the caudate region of postmortem
brainsfromschizophrenicpatientsandcontrolsubjects
with and without other psychiatric disorders (Table 2).
GSH levels were signiﬁcantly (p = 0.017) lower in
patients with schizophrenia than in control subjects
without any psychiatric disorders. A similar reduction
of GSH level was also found in patients with bipolarJ.K. Yao et al. / Altered glutathione redox state in schizophrenia 87
Table 1
Brain collection and storage parameters
Parameters Schizophrenics Controls
without PDa with other PD
Number of samples 12 16 10
Age, years 60 ± 10b 54 ± 17 50 ± 17
Sex (M/F) 9/3 10/6 9/1
Smoking (yes/no) 11/1 10/6 8/2
Postmortem interval (h) 20 ± 14 15 ± 71 6 ± 7
Brain weight (g) 1404 ± 168c 1282 ± 143 1398 ± 77
Storage time (months) 17 ± 8d 11 ± 81 8 ± 8
aPD, psychiatric disorders such as bipolar and depression.
bEach value represents the mean and standard deviation based on the number
of examined brain samples.
cANOVA (F =3 .4482; df =2 .35; p =0 .0430).
dANOVA (F =2 .9450; df =2 .45; p =0 .0658).
Table 2
Evaluation of the glutathione redox system in the caudate region of postmortem brain tissue between schizophrenic
and control groups
Mercaptans Schizophrenics Controls P (two-tailed, unpaired t tests)
(n = 12) without PDa with other PD S vs C S vs C-PD C vs C-PD
(n = 16) (n = 10)
GSHb 107 ± 61c 179 ± 89 115 ± 99 0.017 0.838 0.110
GSSGb 35 ± 24 33 ± 15 30 ± 25 0.870 0.632 0.670
GPx 4658 ± 1199 5825 ± 1775 6294 ± 1210 0.048 0.005 0.432
GR 685 ± 142 794 ± 103 795 ± 218 0.036 0.194 0.997
aAbbreviations: PD, psychiatric disorders; S, schizophrenics; C, control; C-PD, control with psychiatric disorder;
GSH, glutathione; GSSG, glutathione disulﬁde; GPx, glutathione peroxide; GR, glutathione reductase.
bBoth GSH and GSSG were determined by HPLC-CMEAS procedure.
cGSH and GSSG were expressed as ng/mg dry wt., whereas GPx and GR were expressed as mU/mg wet wt.
and/or depression (controls with other types of psy-
chiatric disorders) although it was not statistically sig-
niﬁcant. On the other hand, there were no signiﬁcant
differences of GSSG levels among the three groups of
subjects. Consequently, the ratio of GSH to GSSG
was signiﬁcantly (p = 0.0085) lower in patients with
schizophreniathanin controlsubjectswithoutanypsy-
chiatric disorders (Fig. 2), but not in control subjects
with bipolar and/or depression.
BothGPxandGR activitieswerefoundsigniﬁcantly
(p<0.05) lower in patients with schizophrenia than
in control subjects without any psychiatric disorders
(Table 2). Moreover, GPx activities in patients with
schizophreniawas also signiﬁcantly (p = 0.005) lower
than that of patients with bipolar and/or depression.
However, no signiﬁcant differences were found in ei-
ther GPx or GR between two control groups.
To further assess the GSH redox coupling reactions,
levels of substrate (GSH) were correlated with the spe-
ciﬁcenzymeactivities(GPxorGR).Incontrolsubjects
without any psychiatric disorders, GSH levels were
signiﬁcantly (p = 0.0088) correlated to GPx activities
(Fig. 3). A similar positive correlation (p = 0.0052)
0
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Fig. 2. Comparison of ratio of glutathione (GSH) to glutathione
disulﬁde (GSSG) in postmortem caudates among control subjects
without psychiatric disorders (C), control subjects with other psy-
chiatric disorders (C-PD), and patients with schizophrenia (S). p =
0.0085 (C vs S, two-tailed unpaired t-test).
wasalsodemonstratedbetweenGSHlevelsandGRac-
tivities (Fig. 4). Furthermore, GPx activities were sig-
niﬁcantly (p = 0.0226) correlated to the GR activities
inthesamecontrolgroup(Fig.5). Nosigniﬁcantcorre-
lationswerefoundinpatientswitheitherschizophrenia88 J.K. Yao et al. / Altered glutathione redox state in schizophrenia
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Fig. 3. Correlations of glutathione (GSH) levels to glutathione per-
oxidase (GPx) activities in postmortem caudate region from con-
trol subjects without psychiatric disorders (A), control subjects with
bipolar and/or depression (B), and patients with schizophrenia (C).
or bipolar and/or depression (Figs 3–5).
3.3. Effect of gender and smoking status in GSH
redox state
Although there are more female subjects in the con-
trol samples without psychiatric disorders than in pa-
tient sample groups, no signiﬁcant differences of any
GSH redox measures were found in control samples
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Fig.4. Correlations ofglutathione (GSH)levels toglutathione reduc-
tase (GR) activities in postmortem caudate region from control sub-
jects without psychiatric disorders (A), control subjects with bipolar
and/or depression (B), and patients with schizophrenia (C).
between female (n = 6) and male (n = 10) subjects
(data not shown).
Similarly,therewerenosigniﬁcantdifferencesofany
GSHredoxmeasuresincontrolsamplesbetweensmok-
ers (n = 10) and non-smokers (n = 10) in the present
samplesize(datanotshown). Whennon-smokerswere
excluded from the three test groups, levels of GSH
and GR were still found signiﬁcantly lower in patients
withschizophreniathanincontrolsubjectswithoutpsy-J.K. Yao et al. / Altered glutathione redox state in schizophrenia 89
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Fig. 5. Correlations of glutathione peroxidase (GPx) to glutathione
reductase (GR) activities in postmortem caudate region from con-
trol subjects without psychiatric disorders (A), control subjects with
bipolar and/or depression (B), and patients with schizophrenia (C).
chiatric disorders (Table 3). Likewise, GPx activities
were signiﬁcantly lower in patients with schizophrenia
than in control subjects with bipolarand/ordepression.
A similar trend was also found between patients with
schizophrenia and control subjects without psychiatric
disorders, although the difference was not statistically
signiﬁcant. In addition, GSH levels were also signif-
icantly lower in control subjects with bipolar and/or
depression than in control subjects without psychiatric
disorders (Table 3).
3.4. Effect of age on glutathione reductase reaction
In patients with schizophrenia, both glutathione
disulﬁde (GSSG) and glutathione reductase (GR) were
inversely correlated with age (r = −0.6003,p=
0.039; and r = −0.6124,p=0 .0343, respectively)
in the postmortem caudate region (Figs 6 and 7). Such
inverse correlations were not demonstrated in the con-
trol groups with and without other psychiatric disor-
ders. On the contrary, GR was positively correlated
with age (r =0 .7140,p=0 .0204)of control subjects
with bipolar and/or depressive disorder (Fig. 7).
4. Discussion
4.1. Quantitative determinations of GSH and GSSG
Glutathione plays an important role in metabolism,
transport, redox signaling, and cellular protection. Re-
duced GSH is the major non-protein thiol present in
virtually all cells. Its reducing and nucleophilic prop-
erties protect cells against destructive effects of reac-
tive oxygen species and free radicals [12]. Therefore,
measurements of GSH and its metabolites provide us
with useful indices in studying oxidative damage in
biological samples. A recent review by Camera and
Picardo [13] indicated that GSH levels reported in the
literature vary more than 10-fold mainly due to the
different methodological approaches such as sample
collection, processing and storage, as well as analyti-
cal instruments. To minimize GSH autooxidation and
rapid enzymatic proteolysis of GSH and GSSG, it is
importanttostoresamplesat−70◦C,andprocessunder
refrigeration [13]. Although several chromatographic
methods have been developed to measure GSH and
GSSG, all have some disadvantagesincludingthe need
to formderivatives,the inability to determineGSH and
GSSG simultaneously,and a lack of detectionsensitiv-
ity[14]. HPLCwithelectrochemicaldetectionpresents
a rapid and sensitive approach to measure GSH and
GSSG simultaneously [14,15]. However, detection of
disulﬁdes like GSSG by ECD requires application of
a higher oxidation potential than GSH. In the present
study, we used an HPLC-CMEAS procedure to deter-
mine levels of GSH and GSSG. The CMEAS a 16 ox-
idation potential range from 0 to 1000 mV. The use90 J.K. Yao et al. / Altered glutathione redox state in schizophrenia
Table 3
Comparisons of glutathione redox state in the caudate region of postmortem brain tissue from smokers between
schizophrenic and control groups
Mercaptans Schizophrenics Controls P (two-tailed, unpaired t tests)
(n = 11) without PDa with other PD S vs C S vs C-PD C vs C-PD
(n = 10) (n = 8)
GSH 101 ± 60b 169 ± 95 87 ± 84 0.035 0.350 0.035
GSSG 32 ± 23 35 ± 15 31 ± 29 0.356 0.450 0.339
GPx 4782 ± 1174 5450 ± 1612 6283 ± 1338 0.149 0.012 0.124
GR 688 ± 148 788 ± 104 786 ± 231 0.045 0.159 0.490
aAbbreviations: PD, psychiatric disorders; S, schizophrenics; C, control; C-PD, control with other types of
psychiatric disorder; GSH, glutathione; GSSG, glutathione disulﬁde; GPx, glutathione peroxide; GR, glutathione
reductase.
bGSH and GSSG were expressed as ng/mg dry wt., whereas GPx and GR were expressed as mU/mg wet wt.
of several coulometric sensors in series that are main-
tained at different potentials provides resolution and
detection of co-eluting compounds such as GSH and
GSSG with different electrochemical features. In ad-
dition, a ﬁlter removed macromolecules. This is con-
sidered a valid method to remove proteins because it
does not require addition of acids or organic solvents
that might inﬂuence sample separation, derivatization,
and detection [13].
4.2. Evaluations of GSH redox state in schizophrenia
The present study demonstrated a signiﬁcant de-
creaseofreducedGSHinpostmortemcaudatefrompa-
tients with schizophrenia as compared to control sub-
jects without any psychiatric disorders (Table 2). Such
areductionwasnotassociatedwithbraincollectionand
sample storage parameters. Concomitantly, there was
a signiﬁcant decrease of GSH:GSSG ratio in patients
with schizophrenia (Fig. 2). In cerebrospinal ﬂuid of
drug-free patients with schizophrenia, Do et al. [16]
have previously demonstrated a signiﬁcant decrease in
the levels of GSH as compared to the controls. These
sameauthorsusinganon-invasiveprotonmagneticres-
onance spectroscopy methodology also showed a sim-
ilar reduction of GSH level in medial prefrontal cortex
ofschizophrenicpatients. Ourcurrentﬁndingsarecon-
sistent with these reports and support a hypothesis of
GSH deﬁciencyin schizophrenia. The GSH deﬁciency
induced in the animal model has been related to mito-
chondrialdamage[17,18]andincreasedfreeradicalin-
sult[19,20]. Moreover,severalpathologicalconditions
including Alzheimer’s, Huntington’s, and Parkinson’s
diseaseshavebeenassociatedwithadeﬁciencyofGSH
and imbalanced ratio of GSH to GSSH [21–23].
Furthermore, the present study demonstrated posi-
tive correlations between GSH levels and GPx or GR
activities in postmortem caudate from control subjects
without any psychiatric disorders (Figs 3 and 4). Con-
comitantly, GPx was also signiﬁcantly correlated with
GR activities in control subjects (Fig. 5). These posi-
tive correlations suggest that a dynamic state regulates
the redox coupling under normal conditions. By con-
trast, lack of such correlations in schizophrenia point
to a disturbance of redox coupling mechanisms in the
antioxidant defense system, possibly resulting from a
decreasedlevel of GSH (Table 2)as well as age-related
decreases of GSSG and GR activities (Figs 6 and 7).
4.3. Antipsychotics and the GSH redox state
It is possible that alterations in the GSH redox state
is attributable to the long-term treatment with antipsy-
chotic treatment that these patients likely received. In
the present study, all subjects except control subjects
withoutanypsychiatricdisorderswereonantipsychotic
medications at the time of death. No signiﬁcant dif-
ferences, however, were demonstrated in the caudate
mercaptans between control subjects with or without
non-schizophrenicpsychiatric disorders.
On the other hand, GSH plays a pivotal role in pro-
tectingcells fromoxidativedamagesuch as inducedby
dopamine (DA) oxidation. Recently, Grima et al. [24]
have proposed that GSH deﬁcit in schizophrenia may
be associated with DA-induced oxidative stress. An-
tipsychotic drugs are known to block DA receptors
and consequently, may result in increased levels of
GSH. Therefore, the decreased GSH levels observed
in this study are unlikely due to antipsychotic effects,
because GSH levels may be evenly lower in patients
with schizophrenia or other psychoses in the absence
of antipsychotic treatment.
4.4. Effect of cigarette smoking on GSH redox state
Theprevalenceofcigarettesmokinginschizophrenic
patientsis between70%–90%,comparedto that of35–J.K. Yao et al. / Altered glutathione redox state in schizophrenia 91
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Fig. 6. Correlations of glutathione disulﬁde (GSSG) levels to age in
postmortem caudate region from control subjects without psychiatric
disorders (A), control subjects with bipolar and/or depression (B),
and patients with schizophrenia (C).
54% for all psychiatric patients and 30–35% for gen-
eral population [25–27]. Cigarette smoke contains, in
addition to nicotine, thousands of substances in the gas
and tar phases, many of which are free radicals such
as peroxyl radicals, oxides of nitrogen, hydroquinones
and otherradical species [28–31]. Severalstudies have
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Fig. 7. Correlations of glutathione reductase (GR) activities to age in
postmortem caudate region fromcontrol subjects without psychiatric
disorders (A), control subjects with bipolar and/or depression (B),
and patients with schizophrenia (C).
shown that exposure of isolated cells such as epithe-
lial cells and neutrophils or cultured cells to cigarette
smoke can lead to rapid depletion of intracellular GSH
levels [32–34]. Cigarette smoke induces cell perme-
ability [35,36]and oxidationof lipids and proteins[37,
38] can be prevented by a low-molecular weight an-92 J.K. Yao et al. / Altered glutathione redox state in schizophrenia
tioxidant such as GSH.
As expected, the majority of samples from schizo-
phrenic or bipolar and/or depression groups were ob-
tained from smokers (Table 1). However, the reduced
GSH levels found in both patient groups do not appear
to be related to cigarette smoking (Table 3).
4.5. GSH redox coupling and reactive nitrogen
species
Nitric oxide (NO) is known to have an inhibitory ef-
fect on mitochondrial respiration. Following exposure
to nitric oxide, GSH will react with NO− to form hy-
droxylamineandoxidizedGSH(GSSG),andwithNO+
to produce S-nitrosoglutathione [39]. Moreover, per-
oxynitrite will also react with GSH via either a one or
twoelectronoxidationprocess,dependingonthephys-
iological pH and GSH concentrations [40]. Thus, the
intracellularGSH concentrationappearsto be a critical
factor in dictating susceptibility to NO and its deriva-
tives [41]. Under physiologic conditions, NO and its
metabolites react with a variety of thiol compounds
to form dissociable complexes [42], thereby regulating
its inhibitory function [43]. We have recently demon-
strated a signiﬁcantly increased level of NO in the cau-
date region of postmortem brain from these same indi-
viduals with schizophrenia [44], supporting the notion
of free radical-mediated neurotoxicity in schizophre-
nia. Because the reaction of NO with free thiols com-
peteswiththesamesubstratesuchasglutathione(GSH)
for decomposition of hydrogen peroxide by GSH per-
oxidase, the excessive NO formation may further lead
to signiﬁcant depletion of GSH in schizophrenia.
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